NCT00483054View on ClinicalTrials.gov

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

PHASE3CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2010

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

efavirenz

efavirenz 600 mg/day + stavudine + lamivudine

DRUG

nevirapine

nevirapine 400 mg/day + stavudine +lamivudine

Trial Locations (1)

11000

Bamrasnaradura Infectious Diseases Institute, Nonthaburi

All Listed Sponsors
collaborator

Mahidol University

OTHER

collaborator

Chulalongkorn University

OTHER

lead

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV

NCT00483054 - Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin | Biotech Hunter | Biotech Hunter